- Home
- ONFO vs XRTX Comparison
ONFO vs XRTX Comparison
Compare ONFO & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONFO
- XRTX
- Stock Information
- Founded
- ONFO 2018
- XRTX 2011
- Country
- ONFO United States
- XRTX Canada
- Employees
- ONFO N/A
- XRTX N/A
- Industry
- ONFO Computer Software: Programming Data Processing
- XRTX Pharmaceuticals and Biotechnology
- Sector
- ONFO Technology
- XRTX Health Care
- Exchange
- ONFO Nasdaq
- XRTX Nasdaq
- Market Cap
- ONFO 5.0M
- XRTX 4.4M
- IPO Year
- ONFO 2022
- XRTX N/A
- Fundamental
- Price
- ONFO $1.03
- XRTX $0.72
- Analyst Decision
- ONFO
- XRTX
- Analyst Count
- ONFO 0
- XRTX 0
- Target Price
- ONFO N/A
- XRTX N/A
- AVG Volume (30 Days)
- ONFO 92.1K
- XRTX 5.9M
- Earning Date
- ONFO 11-14-2025
- XRTX 11-14-2025
- Dividend Yield
- ONFO N/A
- XRTX N/A
- EPS Growth
- ONFO N/A
- XRTX N/A
- EPS
- ONFO N/A
- XRTX N/A
- Revenue
- ONFO $10,508,728.00
- XRTX N/A
- Revenue This Year
- ONFO N/A
- XRTX N/A
- Revenue Next Year
- ONFO N/A
- XRTX N/A
- P/E Ratio
- ONFO N/A
- XRTX N/A
- Revenue Growth
- ONFO 78.36
- XRTX N/A
- 52 Week Low
- ONFO $0.61
- XRTX $0.63
- 52 Week High
- ONFO $1.95
- XRTX $1.79
- Technical
- Relative Strength Index (RSI)
- ONFO 44.46
- XRTX 42.75
- Support Level
- ONFO $1.00
- XRTX $0.84
- Resistance Level
- ONFO $1.10
- XRTX $1.41
- Average True Range (ATR)
- ONFO 0.08
- XRTX 0.09
- MACD
- ONFO -0.01
- XRTX -0.02
- Stochastic Oscillator
- ONFO 10.00
- XRTX 11.66
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.